Oxygenta Pharmaceutical Investor Relations Material
Latest events
Q4 24/25
30 May, 2025
Q3 24/25
14 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oxygenta Pharmaceutical Limited
Access all reports
Oxygenta Pharmaceutical Limited is a pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on the production of bulk drugs used in various therapeutic segments, supporting pharmaceutical formulation manufacturers. Its operations include chemical synthesis, quality control, and adherence to regulatory standards for domestic and export markets. The company is headquartered in Visakhapatnam, India, and its shares are listed on the BSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
524636
Country
🇮🇳 India